Guidelines for pacemaker therapy;Leitlinien zur herzschrittmachertherapie

Zeitschrift fur Kardiologie

Volumn 94, Issue 10, 2005, Pages 704-720

  Lemke, B ^a   Nowak, B ^b   Pfeiffer, D ^c  

^a Innere Klinik III   (Germany)

^b CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CAROTID SINUS SYNDROME; DISEASE CLASSIFICATION; ELECTRODE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LONG QT SYNDROME; MORTALITY; NOTE; PRACTICE GUIDELINE; PROGNOSIS; SYNCOPE; TACHYCARDIA; THROMBOEMBOLISM; TREATMENT INDICATION;

ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; GERMANY; GUIDELINE ADHERENCE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 26244450183     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0269-3     Document Type: Note

References (47)

1. Lemke B, Fischer W, Schulten HK (1996) Richtlinien zur Herzschrittmachertherapie. Indikationen, Systemwahl, Nachsorge. "Kommission für Klinische Kardiologie" der Deutschen Gesellschaft für Kardiologie - Herz-und Kreislaufforschung, Arbeitsgruppen " Herzschrittmacher" und "Arrhythmie". Z Kardiol 85:611-627
2. Gregoratos G, Abrams J, Epstein AE et al ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers und antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation) (2002). www.acc.org/clinical/guidelines/pacemaker/pacemaker.pdf
3. Strasberg B, Amat-Y-Leon F, Dhingra RC et al (1981) Natural history of chronic second-degree atrioventricular nodal block. Circulation 63:1043-1049
4. Dhingra RC, Denes P, Wu D, Chuquimia R, Rosen KM (1974) The significance of second degree atrioventricular block and bundle branch block: observations regarding site and type of block. Circulation 49:638-646
5. Dhingra RC, Wyndham C, Bauernfeind R et al (1979) Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation 60:1455-1464
6. Scheinman MM, Peters RW, Sauvè MJ et al (1982) Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 50:1316-1322
7. Perloff JK, Stevenson WG, Roberts NK et al (1984) Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients. Am J Cardiol 54:1074-1081
8. Charles R, Holt S, Kay JM, Epstein EJ, Rees JR (1981) Myocardial ultrastructure and the development of atrioventricular block in Kearns-Sayre syndrome. Circulation 63:214-219
9. Stevenson WG, Perloff JK, Weiss JN, Anderson TL (1990) Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. J Am Coll Cardiol 15:292-299
10. Shaw DB, Kerwick CA, Veale D, Gowers J, Whistance T (1985) Survival in second degree atrioventricular block. Br Heart J 53:587-593
11. Moak JP, Barron KS, Hougen TJ et al (2001) Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 37:238-242
12. Pinsky WW, Gillette PC, Garson A Jr, McNamara DG (1982) Diagnosis, management, and long-term results of patients with congenital complete atrioventricular block. Pediatrics 69:728-733
13. Michaëlsson M, Jonzon A, Riesenfeld T (1995) Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 92:442-449
14. Brignole M, Menozzi C, Moya A et al (2001) Mechanism of synkope in patients with bundle branch block and negative electrophysiological test. Circulation 104:2045-2050
15. McAnulty JH, Rahimtoola SH, Murphy ES et al (1982) Natural history of "high risk" bundle-branch block: Final report of a prospective study. N Engl J Med 307:137-143
16. Brignole M, Alboni P, Benditt D et al (2004) Guidelines on Management (Diagnosis and Treatment) of Syncope - Update 2004. Europace 6:467-537
17. Scheinman MM, Peters RW, Sauvè MJ et al (1982) Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 50:1316-1322
18. Cazeau S, Leclercq C, Lavergne T et al Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873-880
19. Auricchio A, Stellbrink C, Block M et al for the PATH-CHF Study Group (1999) The effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 99:2993-3001
20. Abraham WT, Fisher WG, Smith AL et al, for the MIRACLE Study Group (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845-1853
21. Cleland JGF, Daubert JC, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in hear failure. N Engl J Med 352:1539-1549
22. Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure. N Engl J Med 350:2140-2150
23. Auricchio A, Stellbrink C, Sack S et al for the Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group (2002) Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39:2026-2033
24. Higgins SL, Hummel JD, Niazi IK et al (2003) Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 42:1454-1459
25. Auricchio A, Stellbrink C, Butter C et al (2003) Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 42:2109-2116
26. Stellbrink C, Auricchio A, Lemke B, von Scheidt W, Vogt J (2003) Positionspapier zur kardialen Resynchronisationstherapie. Z Kardiol 92:96-103
27. Col JJ, Weinberg SL (1972) The incidence and mortality of intraventricular conduction defects in acute myocardial infarction. Am J Cardiol 29:344-350
28. Ritter WS, Atkins J, Blomqvist CG, Mullins CB (1976) Permanent pacing in patients with transient trifascicular block during acute myocardial infarction. Am J Cardiol 38:205-208
29. Seidl K, Schuchert A, Tebbenjohanns J et al (2005) Kommentar zu den Leitlinien zur Diagnostik und Therapie von Synkopen - der Europäischen Gesellschaft für Kardiologie 2001. www.dgk.org/leitlinien/LLSynkopen2005. pdf
30. Bernstein AD, Daubert JC, Fletcher RD et al (2002) The Revised NASPE/ BPEG Generic Code for Antibradycardia, Adaptive-Rate, and Multisite Pacing. PACE 25:260-264
31. Andersen HR, Nielsen JC, Thomsen PEB et al (1997) Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 350:1210-1216
32. Connolly SJ, Kerr CR, Gent M et al (2000) Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 342:1385-1391
33. Lamas GA, Kerry LL, Sweeney MO et al (2002) Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 346:1854-1862
34. Tang ASL, Roberts RS, Kerr C et al (2001) Relationship between pacemaker dependency and the effect of pacing mode on cardiovascular outcomes. Circulation 103:3081-3085
35. Mattioli AV, Vivoli D, Mattioli G (1998) Influence of pacing modalities on the incidence of atrial fibrillation in patients without prior atrial fibrillation. A prospective study. Eur Heart J 19:282-286
36. Lamas GA, Orav EJ, Stambler BS et al, for the Pacemaker Selection in the Elderly Investigators (1998) Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 338:1097-1104
37. Kerr CL, Connolly SJ, Abdollah H et al (2004) Canadian trial of physiological pacing. Effects of physiological pacing during long-term follow-up. Circulation 109:357-362
38. Sweeney MO, Hellkamp AS, Ellenbogen KA et al (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932-2937
39. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PEB (1994) Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 344:1523-1528
40. Aggarwal RK, Connelly DT, Ray SG et al (1995) Early complications of permanent pacemaker implantation: No difference between dual and single chamber systems. Br Heart J 73:571-575
41. Rosenqvist M, Brandt J, Schüller H (1988) Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 116:16-22
42. Wiegand UKH, Schier H, Bode F et al (1998) Should unipolar leads be implanted in the atrium? A Holter electrocardiographic comparison of threshold adapted unipolar and high sensitive bipolar sensing. PACE 21:1601-1608
43. Gross JN, Platt S, Ritacco R et al (1992) The clinical relevance of the elektromyopotential oversensing in current unipolar devices. PACE 15:2023-2027
44. Moller M, Arnsbo P (1996) Appraisal of pacing lead performance from the Danish Pacemaker Register. PACE 19:1327-1336
45. Wiegand UKH, Bode F, Bonnemeier H, Tölg R, Peters W, Katus HA (2001) Incidence and predictors of pacemaker dysfunction with unipolar ventricular lead configuration. Can we identify patients who benefit from bipolar electrodes? PACE 24:1383-1388
46. Martinelli M, Costa R, Nishioka S et al (2002) Criteria for pacemaker explant in patients without a precise indication for pacemaker implantation. PACE 25:272-277
47. Hemmer W, Fröhlig G, Markewitz A (2002) Kommentar zu den NASPE-Empfehlungen zur Entfernung von permanent implantierten, transvenösen Herzschrittmacher- und Defibrillatorsonden. Z Kardiol 91:956-968